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Technetium-99 m medronateAbstract Male patient, 35 years old, with occasional mild intensity back pain. Lumbosacral spine
radiography showed bone structure with increased density, diffusely and symmetrically, conferring
to the vertebral bodies ‘‘bone-within-bone’’ aspect, suggesting osteopetrosis (OP). Whole-body
bone scintigraphy showed abnormal uptake in proximal epiphysis of both the humeri, tibias and
ﬁbulas, distal epiphysis of the femurs and focal in the ribs suggesting old fractures. Conclusions:
Nuclear Medicine may provide an important contribution as supporting diagnosis and extensive
skeletal evaluation such as fractures and infection. Bone scintigraphy might also be used for base-
line assessments, allowing longitudinal monitoring of the disease and patient follow-up.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.1. Introduction
First described by the German radiologist Albers-Scho¨nberg in
1904 (1), osteopetrosis (OP) is a rare heterogeneous group of
inherited hereditary metabolic skeletal disorders, which is usu-ally non-sex-linked, manifested by increased bone mass and
density due to impaired bone resorption by osteoclasts, with
generalized cortical sclerosis and bone trabeculae remarkably
thickened, resulting in marrow space compression with
reduced hematopoiesis and skeletal deformity (2). It has been
called ‘‘marble bone disease’’ because of the replacement of
the trabecular bone with compact bone, resulting in very dense
bones radiographically, although they typically have increased
susceptibility to fracture (3). The osteoclast activity impedes
bone remodeling process, and seriously damages bone forma-
tion and structure, with failure of cartilaginous and bone
matrix (4). The overall incidence of OP is estimated to be only
1 case per 100,000–500,000 population (5).
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are at least eight human phenotypes (6) and three distinct types
of OP: the infantile, ‘‘malignant’’ or ‘‘lethal’’ form, which has
precocious onset and is clinically severe, the autosomal reces-
sive or ‘‘intermediate’’ form and the autosomal dominant form
(5). Albers-Scho¨nberg disease, which is a relatively mild auto-
somal dominant form of OP type II, is the most common one
and occasionally skips generations (6). There are various forms
with the benign (‘‘tarda’’) variant of OP transmitted as an
autosomal dominant trait. Three molecular defects have been
identiﬁed that compromise the genes encoding carbonic anhy-
drase II (CA II), chloride channel 7, and a proton-pump sub-
unit; together, these proteins enable osteoclasts to secrete acid
(6). The disease is caused by ineffective osteoclastic function
resulting from mutations in the chloride channel 7 (ClCN7)
gene. Chloride inﬂux into osteoclast by exchange of bicarbon-
ate is important for the formation of HCl-mediated mecha-
nism of bone resorption. Individuals with autosomal
dominant OP type II have increased numbers of large ineffec-
tive osteoclasts in addition to increased serum total tartrate-
resistant acid phosphatase (TRACP) activity (2). Patients with
OP have fragile osteosclerotic bone with increased serum levels
of the bone formation markers: bone alkaline phosphatase iso-
enzyme, osteocalcin and N-terminal type I collagen telopep-
tide/creatinine ratio (2). Following the assignment of the
gene causing autosomal dominant osteopetrosis (ADO) type
II to chromosome 16p13.3, seven different mutations in the
gene encoding the ClCN7 chloride channel have been reported
(2). Autosomal recessive, infantile form of OP homozygous for
a ClCN7 mutation is a fatal disease without bone marrow
transplantation. Its incidence has been underestimated possi-
bly because some cases in the stillborn infant or in those dying
soon after birth may go undiagnosed. It is more frequently
seen in countries where inbreeding is common such as Costa
Rica or Saudi Arabia (7).
There is some variability in the severity of different clinical
manifestations in different families. In some families, the
symptoms related to the OP dominate the clinical picture. Pre-
vious studies suggested that clinical heterogeneity is due to
genetic heterogeneity.
Patients with autosomal dominant OP are often asymptom-
atic, and the diagnosis may be reached by chance. However, by
systematic investigations, nearly all patients have manifesta-
tions related to the disorder. Symptoms are progressive with
age and correlate with osteosclerosis (3).
Although affected individuals can have a normal life expec-
tancy and remain asymptomatic, there is a well-known propen-
sity for fractures, which might not heal satisfactorily (4).
Defective skeletal remodeling in patients with OP compromises
bone quality, resulting in disorganized bony architecture,
because the removal of primary spongiosa and the intercon-
nection of osteons are impaired. When the bones are exten-
sively implicated, it is no longer possible to distinguish
between corticalis and spongiosa, and in affected long bones,
even the major marrow cavities may no longer be clearly
discernible (8). Consequently, spondylolysis (leading to spond-
ylolisthesis) seems more prevalent in such patients, and other
fractures are established complications of the disease (6).
Autosomal dominant OP may be a heterogeneous group.
Albers-Schonberg disease is characterized by diffuse osteoscle-
rosis with defective tabulation and thickened cortices, predom-
inantly involving the spine (vertebral end-plate thickening, orrugger-jersey spine, similar to that of Paget´s disease), pelvis
(‘‘bone-within-bone’’ structures, with iliac wings containing
convex arcs of sclerotic bone) (3), and skull base. Affected
persons may be relatively asymptomatic, or the disease may
be detected because of pathologic fractures, mild anemia, or
cranial nerve palsies. The disorder is compatible with a normal
life span and is referred to as the adult or benign form of OP
(3). Myelophthisic anemia (anemia characterized by the
appearance of immature myeloid white cells and nucleated
erythrocytes in the peripheral blood) can develop as a result
of the overgrowth of sclerotic bone obliterating the marrow
cavity, but the severity of anemia, if present, does not necessar-
ily parallel the degree and extent of sclerosis (4). In contrast, in
autosomal dominant OP type I, the most striking ﬁnding is
pronounced sclerosis, which predominantly involves the cra-
nial vault, while the spine is almost unaffected, with less frac-
ture risk (2,3). However, in both types, the disease may have its
clinical onset after the arterial and neural foramina have
reached their adult size; hence, narrowing of the foramina
and canals may not occur. Biochemically, serum phosphate
is found to be lower in type I than in type II, and serum acid
phosphatase is markedly increased in type II (3). The
osteoclasts are found markedly reduced in number and size
in type I, but in type II, the osteoclasts are large and highly
multinucleated, with increased number (3). In addition, serum
carboxy-terminal propeptide of type I collagen (S-PICP) is
found to be signiﬁcantly lower in autosomal dominant OP type
II. Serum osteocalcin values in the two types of autosomal
dominant OP have been observed to be insigniﬁcantly lower
than in controls (3).
A more uncommon form of the disease, intermediate OP,
also demonstrates autosomal recessive inheritance. However,
this variant tends to present later in childhood than the more
malignant form. Typically, these patients have short stature
and experience some of the more aggressive features of malig-
nant OP (9). Frequently, IOP (intermediate OP) is distin-
guished from the malignant form only when a milder clinical
course evolves with age.
Children affected by more serious forms of the disease,
apart from bone deformities, may also suffer from anemia,
leukopenia, hepatomegaly, failure to thrive (3), and central
nervous system disorders (3,5). Neurological sequel such as
cranial nerve compression with blindness (optic atrophy), deaf-
ness, or facial nerve paresis is also seen. Other manifestations
include stenoses of the petrous internal carotid artery (ICA),
jugular veins within narrowed jugular foramina, and cervical
vertebral arteries within narrowed transverse foramina (9).
Occasionally, these are accompanied by hydrocephalus, con-
vulsions, and mental retardation (7). In children, pancytopenia
(malignant OP) occurs due to gradual obliteration of the
medullary cavity. Therefore, special attention should be paid
to infectious complications. The disease may result in demise
usually within the ﬁrst decade of life, owing to hemorrhage
from thrombocytopenia and fatal infection from leukocytope-
nia (5,10). As a general rule, the earlier the clinical presenta-
tion, the more malignant is the disease.
Interestingly, in some patients, symptoms are few. In such
cases, relatively benign and asymptomatic conditions are often
diagnosed as OP by radiography and other biochemical
ﬁndings, but complications like osteomyelitis and multiple
fractures may be missed by X-ray alone (5). Magnetic
Ressonance (MR) or Computed Tomography (CT) is highly
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nerve channels and neuropathic changes, such as cerebral
atrophy and agenesis of corpus callosum.
Whole-body bone scintigraphy is a sensitive method for
detecting bone lesions at an earlier phase. It can also reveal
a much more extensive involvement of the skeleton, studying
the whole body with minor radiation exposure to patient,
which has especial interest in children examination, and be
useful in the diagnosis of complications such as fractures and
osteomyelitis. In this study, a case of OP in a male patient is
presented.2. Case report
Male patient, 35 years old, with occasional mild intensity back
pain. Lumbosacral spine radiography performed during the
admission showed bone structure with increased density,
diffusely and symmetrically, conferring to the vertebral bodies
‘‘bone-within-bone’’ aspect, suggesting OP (see Fig. 1). In
subsequent evaluation, whole-body bone scintigraphy with
methylene diphosphonate labeled with technetium-99 m
(MDP–99mTc) was performed, which showed abnormal
uptake in the ribs, proximal epiphysis of both the humeri, tib-
ias and ﬁbulas, and distal epiphysis of the femurs. Kidneys and
bladder were not visible, suggesting bone superscan (see
Fig. 2).
3. Discussion
All forms of OP are associated with failure to resorb bone (3).
An impaired hypercalamic response to infuse parathyroid
hormone (PTH) has been demonstrated in OP. The cause for
this impairment might differ in different forms of OP. Studies
showing inhibition of PTH-induced release of calcium from
bone by CA inhibitors have suggested a role for CA in bone
resorption. On the basis of these and other observations, it
has been suggested that PTH activates CA in certain bone cellsFig. 1 Lumbosacral spine radiography performed during the admissi
and symmetrically, conferring to the vertebral bodies ‘‘bone-within-boand promotes bone resorption by facilitating the secretion of
hydrogen ions (3). Carbonic anhydrase II deﬁciency is the
primary defect in the syndrome of autosomal recessive OP
(3). However, it has been demonstrated that CA II does not
seem to play any pathogenetic role in the two forms of autoso-
mal dominant OP (3).
One subset of patients with OP has mutations in the gene
for carbonic anhydrase II resulting in CA II deﬁciency (2).
Osteoclasts in these patients are unable to generate hydrogen
ions (acidiﬁcation) necessary for bone resorption. Further-
more, OP due to osteoclast proton pump deﬁciency has been
reported (2). The patients have severe OP presenting in infancy
with visual impairment and frontal bossing, hepatosplenomeg-
aly, hypocalcemia, and death in the ﬁrst decade of life. Genetic
testing of rare bone disease such as OP and others is still not
commonly available (2).
The radiological ﬁndings of OP are well known and include
increasing osteosclerosis without corticomedullary demarca-
tion and formation of bone-in-bone or endobone phenomena.
Bones may be uniformly sclerotic, but alternating sclerotic and
lucent bands may also be noted in the iliac wings and at the
epiphysis of long bones (especially distant radius, ulna, and
proximal humerus, and even small tubular bones of the hands
and feet and the skull base). Metaphyseal long bone-modeling
deformities (Erlenmeyer ﬂask deformity) and obliteration of
the skull diploic cavity, especially at the base with neural
foraminal encroachment and sclerotic vertebral bodies, often
with a ‘‘sandwich vertebra’’ appearance, can be found (4) as
OP encompasses a heterogeneous group of disorders, and
ﬁndings differ according to the type of OP (5).
Based on standard radiographs, it is possible to describe
two different subtypes with different clinical, biochemical,
and histologic manifestations. Type I is radiographically
characterized by pronounced osteosclerosis of the cranial
vault, whereas type II has end-plate thickening of the vertebrae
(rugger-jersey spine) and endobones in the pelvis.
Differential diagnosis of rugger-jersey spine includes
primary hyperparathyroidism, renal osteodystrophy, Paget´sonal exam showed bone structure with increased density, diffusely
ne’’ aspect, suggesting OP.
Fig. 2 Whole-body bone scintigraphy with MDP–99mTc showing abnormal uptake in proximal epiphysis of both the humeri, tibias and
ﬁbulas, distal epiphysis of the femurs, and focal in the ribs suggesting old fractures. Kidneys and bladder were not visible, suggesting bone
superscan.
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urinary deoxypyridinoline (DPD), and serum TRACP might
be helpful in differentiating these two diseases. The levels of
urinary DPD are increased in patients with Paget´s disease,
reﬂecting increased osteoclastic activity being inhibited in
patients with autosomal dominant OP type II. Commonly,
Paget’s Disease is a process localized to one or several regions
of the skeleton, occasionally, it is widespread and severe,
producing extensive osseous abnormality and deformity (2).
Otherwise, the typical bone scan in uncomplicated osteopetro-
sis reﬂects the elevated mineralization in the metaphysic of
tubular bones that demonstrate increased tracer uptake in
the metaphysic, whereas the axial skeleton is spared. Fracture
sites are seen as foci of increased activity (11). In this case,
bone scan is presented as typically described in scientiﬁc
literature: abnormal (increased) uptake in proximal epiphysis
of both the humeri, tibias and ﬁbulas, and distal epiphysis of
the femurs, associated with focal low to moderate uptake in
the ribs suggesting same areas of old bone fractures. Despite
the low prevalence of osteopetrosis, 1 case per 100,000–
500,000, as described previously in this text, the nuclear
physician should be aware of the bone scintigraphic features
of OP because patients might be asymptomatic and bone scancould be the ﬁrst diagnostic study to and be a incidentally
found (11).
Elevated radiodensity and particular ﬁndings in X-ray
analysis usually lead to the diagnosis of OP. X-ray of all bones
should be avoided. Pictures of at least one extremity, the head
and the thorax should be performed to describe the morphol-
ogy and extent of osteosclerosis, bone marrow narrowing and
head deformities. In addition, radiological analysis of the brain
and skull by MR or CT is highly recommended to detect
hydrocephalus, narrowing of central nerve channels and
neuropathic changes, such as cerebral atrophy and agenesis
of corpus callosum. MRI is preferable for radiation protection
and better quality.
The diagnosis of OP is not generally a challenge since most
radiologists easily recognize the characteristic dense and
poorly remodeled bones seen on conventional radiographs.
Although the diagnosis is straightforward, its therapy is
complex. Proper medical management requires the combined
sophisticated skills of the endocrinologist, hematologist and
imaging professionals.
Although, like in these cases, X-ray already suggested the
diagnosis of osteopetrosis, bone scan is a complementary
imaging tool to conﬁrm the X-Ray founds, differentiating
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the study of the whole body in one unique exam with a low
radiation dose (6.3 mSv). It also turns possible visualization
of extensive skeleton involvement, metabolically active lesions,
which are more apt to cause symptoms (2), and fractures, seen
in these cases, and osteomyelitis, both common complication
of OP secondary, respectively, to fragile osteosclerotic bone
and marrow failure.
Concern with radioprotection is especially important in
infants where CT should be avoided. A disadvantage of
radiology is its use for studying speciﬁc sites of the body, turn-
ing difﬁcult to encounter poliostotic diseases.
Radiology and scintigraphy offer valuable additional
information, which conﬁrms the supplements and supports
the clinical and biochemical evaluation (2).
The heterogeneity of the disease causes a considerable
variation in the extent and degree of skeletal involvement
(12). Bone scintigraphy with bisphosphonates has been found
to show bone deformities and sites of old and new fractures.
Sometimes, bone scan has been observed to exhibit diffusely
increased tracer uptake similar to a superscan.
In the follow up period after therapy, bone scan is recom-
mended to be repeated, since new asymptomatic bone fracture
may be misdiagnosed (5). It may be useful in the evaluation of
osteomyelitis recurrence where no radiographic changes are
shown. It may also complement the radiographic studies for
evaluation of multiple fractures.
Not only bone scan could help in the management of
patients with OP. Bone Marrow Scintigraphy can be used to
evaluate hemaptopoiesis in osteopetrosis, providing a direct
whole-body method for visualizing the marrow space (13).
OP warrants treatment because of the adverse outcome
associated with the disease (5). Current therapeutic approaches
are based on different pathogenetic considerations. The
assumed failure of osteoclasts causing diminished resorption
of calciﬁed cartilage is treated with high doses of calcitriol,
which has been experimentally found to be effective in
stimulating osteoclast formation and function (7). Vitamin
D3 (calciferol) appears to help by stimulating dormant osteo-
clasts and, thus, bone resorption. For patient management, the
grade of bone marrow displacement and the resulting hemato-
poietic dysfunction need to be known. Treatment with gamma
interferon has offered long-term beneﬁts by improving white
blood cell function and decreasing the incidence of new
infections. Erythropoietin can be used to correct anemia. Cor-
ticosteroids have also been used to treat anemia as well as to
stimulate bone resorption. In pediatric OP, surgical treatment
of fractures may be necessary (5). Autosomal recessive form of
OP is potentially reversible by allogeneic bone marrow trans-
plantation with engraftment of normal functioning osteoclasts
(10). By providing large numbers of osteoclast precursors,
bone marrow transplantation induces normal bone resorption
and reversal of the osteopetrotic state (7).
4. Conclusions
The role of imaging is fundamental in OP. Despite X-ray may
do the diagnose alone, nuclear medicine may be helpful when
the radiographic imaging is not typical and in complicated
forms of the disease that courses with fractures andosteomyelitis. It also provides an important contribution as
being the ﬁrst diagnostic approach, especially in assintomatic
patients, supporting diagnosis in OP. Bone scintigraphy might
also be used for extensive skeletal evaluation, since X-ray of all
bones should be avoided and because metabolically active
lesions are more apt to cause symptoms. Bone scan also
contributes to the follow-up of these patients, allowing longitu-
dinal monitoring of the disease since new asymptomatic bone
fracture may be diagnosed (5) and recurrence of osteomyelitis
where no radiographic change is shown. Thus, serial whole-
body scans may be useful both in symptomatic and even in
asymptomatic patients with OP.
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